AUG 07, 2018 8:50 PM PDT

Improving Liver Cancer Therapy

WRITTEN BY: Nouran Amin

According to studies conducted in the United States, the ninth leading causes of cancer deaths is hepatocellular carcinoma, the primary cancer of the liver. Hepatocellular carcinoma tends to grow and expand at an increasingly fast rate and if not diagnosed early on then affected individuals may not always survive longer than 11 months. Specialists seek to treat their patients by usually prescribing a therapeutic drug known as "sorafenib." However, the drug will typically prolong the survival of individuals by only 3 months, and it can bring numerous negative side-effects.

Watch Alternative Treatment Options:

To seek other options in an effort to improve liver cancer treatment, cancer researchers from multiple international institutions have collaborated together to treat a therapeutic drug that holds high efficacy for the treatment of liver cancer. The compound was developed primarily by researchers from the Cancer Institute of Singapore at the National University of Singapore in Queenstown along with colleagues from other global institutions.

The new experimental drug, which researchers refer to as "FFW", holds the potential to treat liver cancer by improving survival rates and lessening adverse effects additionally it is believed to alter the growth of primary liver cancer and help reduce the unwanted effects of typical therapy. In the journal PNAS, the development of FFW is outlined by the researchers in the most recent publication. "In our latest work, [we have] demonstrated an effective strategy to accurately target oncogenes previously considered undruggable," says study co-author and professor at the National University of Singapore, Daniel Tenen.

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 19, 2022
Health & Medicine
Pandemic Creates Opportunity to Study Rare Vaccine Side Effects
APR 19, 2022
Pandemic Creates Opportunity to Study Rare Vaccine Side Effects
The Global Vaccine Data Network (GVDN) is a project conceived over 10 years ago to study vaccine side effects. Back then ...
APR 21, 2022
Cannabis Sciences
One of the most lucrative skillsets in cannabis
APR 21, 2022
One of the most lucrative skillsets in cannabis
For anyone looking for a well-compensated, in demand job in the cannabis industry, you can't go wrong with becoming an e ...
MAY 25, 2022
Neuroscience
Exploring Drug Targets in Neurodegenerative Diseases
MAY 25, 2022
Exploring Drug Targets in Neurodegenerative Diseases
Introduction Life expectancy has increased globally over the last several decades. However, longer life expectancy comes ...
JUN 06, 2022
Cannabis Sciences
Price and Convenience: Key Reasons Why People Continue to Buy Illegal Cannabis
JUN 06, 2022
Price and Convenience: Key Reasons Why People Continue to Buy Illegal Cannabis
A study published in the Journal of Studies on Alcohol and Drugs found that price and convenience are the two main reaso ...
JUN 13, 2022
Microbiology
Mucus Contains Fungus-Fighting Molecules
JUN 13, 2022
Mucus Contains Fungus-Fighting Molecules
The human body plays host to a variety of microorganisms, including fungi like Candida albicans. Some strains of Candida ...
JUN 27, 2022
Plants & Animals
Developing a New Approach to Rabies Vaccination
JUN 27, 2022
Developing a New Approach to Rabies Vaccination
Rabies is a viral disease that can spread through the saliva. Several kinds of animals can get rabies, including humans ...
Loading Comments...